Unichem Laboratories

Innovation that improves lives


Over the years, Unichem has invested significantly in Research and Development (R&D) to create state-of-the-art R&D facilities. Backed by a research team of over 300+ highly-trained scientists with excellent credentials, the company’s R&D facilities are equipped with cutting-edge pharmaceutical research technology.

Unichem’s laboratories are equipped with the latest sophisticated analytical instruments like ICPMS, XRPD, NMR, GC, LCMS, GCMS, Particle size analyser, IR/UV, TGA, DSC, Prep HPLC and Flash Chromatography.

The company expanded its R&D facilities to strengthen Chemical and Formulation research capabilities. Its Biotechnology R&D facility focuses on cost-effective Bio-Catalysis, Biosimilar products and Novel Biological Entities or Novel Chemical Entities using recombinant microorganisms. It is geared to provide a new edge to Unichem’s R&D efforts.



Unichem’s R&D activities are focused on the following:
  • Novel cost-efficient process development for Active Pharmaceutical Ingredients (APIs) and intermediates
  • Platform cost-efficient Recombinant Technology Development for Peptides, Proteins, Enzymes etc.
  • Formulation development for Generic APIs, Biosimilars
  • Formulation Development of OSDs, Injectables
  • Formulation Development in Novel Drug Delivery Systems for Complex Generics
  • Non-infringing routes for manufacturing products to be marketed internationally
  • Computer Aided Drug Discovery of NCEs, NBEs, Enzymatic Catalysts
  • Contract research to develop formulations for New Chemical Entities (NCEs) and Generic APIs

Inspired by an ambition to drive path-breaking innovative research, Unichem aims to improve people’s health by consistently providing better, more effective and safe products.